News Former President of Eli Lilly Research Labs and Head of R&D Dr. Jan Lundberg invests in Sigrid Therapeutics and joins the Company’s Scientific Advisory Board By Liu Ming | News | No Comments
News Major Swedish study provides additional proof of concept for Sigrid’s medical device SiPore15 for preventing diabetes and treating obesity By Liu Ming | News | No Comments
News The Stockholm Material Hub, of which Sigrid Therapeutics is a long-term collaborator of, receives €0.5 M boost from European Regional Development Fund By Liu Ming | News | No Comments
News Stockholm Material Hub, vilken Sigrid Therapeutics är en nyckelpartner till, erhåller €0,5 miljoner i bidrag från Europeiska Regionala Utvecklingsfonden By Liu Ming | News | No Comments
News New study in mice published in Nanomedicine shows Sigrid’s medical device SiPore15 prevents weight gain By Liu Ming | News | No Comments
News Sigrid Therapeutics Takes Another Step Towards a Treatment for Prevention of Type 2 diabetes By Liu Ming | News | No Comments
News Stockholm-based technology startup Sigrid Therapeutics, developing SiPore15TM – a breakthrough device to lower blood sugar levels, closes oversubscribed round of $1.6M, bringing total pre-launch funding to $9M By Liu Ming | News | No Comments
News Sigrid Therapeutics announces that all patients have completed treatment with SiPore15 in the STAR Trial By Morgan | News | No Comments
News Sigrid Therapeutics STAR Trial of SiPore15 Showing Rapid Progress By Morgan | News | No Comments
News Sigrid Therapeutics Announces SiPore15 Selected for Oral Presentation at Upcoming 28th European Diabetics Congress in Edinburgh By Morgan | News | No Comments
